← Leaderboards
Victor E Laubach
University Of Virginia Charlottesville
$15,022,296
Attributed
$23,729,488
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,729,488 · 10
By mechanism
R01$20,496,243 · 9
T32$3,233,245 · 1
Top collaborators
- Irving L Kron25 shared
- Swapnil K. Sonkusare4 shared
- Mark Roeser2 shared
- Zequan Yang2 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Irving L Kron$20,314,863
- Adrian R Gear$1,628,741
- Joel M. Linden$14,399,863
- Steven M Fiser$39,232
- Umesh S Deshmukh$7,411,901
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungLung TransplantationTransplantationCellsAlveolarLung IschemiaMediatingReperfusion InjuryReceptorNeutrophilEpithelial CellsPreventAcuteFunctional DisorderSourceAgonistLeukocytesMacrophageInflammationInjuryTransplant RecipientsIn VivoAttenuatedBone Marrow
Grant awards (47)
Targeted treatment of acute lung injury using isolated lung perfusion$806,617
R01 · FY2025 · HL
Cardiovascular Surgery Training Program$425,604
T32 · FY2025 · HL · contact PI
Targeted treatment of acute lung injury using isolated lung perfusion$800,467
R01 · FY2024 · HL
Role of TRPV4 channel signaling in lung ischemia-reperfusion injury$689,589
R01 · FY2024 · HL · contact PI
Cardiovascular Surgery Training Program$543,452
T32 · FY2024 · HL · contact PI
Role of TRPV4 channel signaling in lung ischemia-reperfusion injury$704,931
R01 · FY2023 · HL · contact PI
Cardiovascular Surgery Training Program$526,513
T32 · FY2023 · HL · contact PI
Role of TRPV4 channel signaling in lung ischemia-reperfusion injury$662,276
R01 · FY2022 · HL · contact PI
Cardiovascular Surgery Training Program$508,979
T32 · FY2022 · HL · contact PI
Role of TRPV4 channel signaling in lung ischemia-reperfusion injury$657,805
R01 · FY2021 · HL · contact PI
In Vivo Lung Perfusion for the Surgical Treatment of Acute Respiratory Distress Syndrome$580,182
R01 · FY2021 · HL · contact PI
Cardiovascular Surgery Training Program$490,842
T32 · FY2021 · HL · contact PI
Adenosine A2 Receptors and Imaging of Inflammation in Lung Reperfusion Injury$658,089
R01 · FY2020 · HL · contact PI
In Vivo Lung Perfusion for the Surgical Treatment of Acute Respiratory Distress Syndrome$580,182
R01 · FY2020 · HL · contact PI
Pannexin-1 Signaling in Lung Ischemia-Reperfusion Injury$558,452
R01 · FY2020 · HL · contact PI
Adenosine A2 Receptors and Imaging of Inflammation in Lung Reperfusion Injury$658,089
R01 · FY2019 · HL · contact PI
In Vivo Lung Perfusion for the Surgical Treatment of Acute Respiratory Distress Syndrome$580,182
R01 · FY2019 · HL · contact PI
Pannexin-1 Signaling in Lung Ischemia-Reperfusion Injury$558,452
R01 · FY2019 · HL · contact PI
Cardiovascular Surgery Training Program$312,296
T32 · FY2019 · HL · contact PI
Adenosine A2 Receptors and Imaging of Inflammation in Lung Reperfusion Injury$658,089
R01 · FY2018 · HL · contact PI
In Vivo Lung Perfusion for the Surgical Treatment of Acute Respiratory Distress Syndrome$579,733
R01 · FY2018 · HL · contact PI
Pannexin-1 Signaling in Lung Ischemia-Reperfusion Injury$558,069
R01 · FY2018 · HL · contact PI
Cardiovascular Surgery Training Program$425,559
T32 · FY2018 · HL · contact PI
Adenosine A2 Receptors and Imaging of Inflammation in Lung Reperfusion Injury$658,089
R01 · FY2017 · HL · contact PI
Ex vivo perfusion in a lung box for rehabilitation of donor lungs$657,544
R01 · FY2017 · HL
Pannexin-1 Signaling in Lung Ischemia-Reperfusion Injury$614,784
R01 · FY2017 · HL · contact PI
Ex vivo perfusion in a lung box for rehabilitation of donor lungs$657,544
R01 · FY2016 · HL
Ex vivo perfusion in a lung box for rehabilitation of donor lungs$647,681
R01 · FY2015 · HL
Ex vivo perfusion in a lung box for rehabilitation of donor lungs$656,152
R01 · FY2014 · HL
Ex vivo perfusion in a lung box for rehabilitation of donor lungs$641,215
R01 · FY2013 · HL
T cell-mediated lung ischemia-reperfusion injury$362,855
R01 · FY2013 · HL · contact PI
T cell-mediated lung ischemia-reperfusion injury$381,150
R01 · FY2012 · HL · contact PI
T cell-mediated lung ischemia-reperfusion injury$385,000
R01 · FY2011 · HL · contact PI
Adenosine receptor activation in pulmonary ischemia-reperfusion injury$378,750
R01 · FY2011 · HL
Adenosine receptor activation in pulmonary ischemia-reperfusion injury$378,750
R01 · FY2010 · HL
T cell-mediated lung ischemia-reperfusion injury$375,280
R01 · FY2010 · HL · contact PI
Adenosine receptor activation in pulmonary ischemia-reperfusion injury$378,750
R01 · FY2009 · HL
Adenosine receptor activation in pulmonary ischemia-reperfusion injury$18,550
R01 · FY2009 · HL
Adenosine receptor activation in pulmonary ischemia-reperfusion injury$371,025
R01 · FY2008 · HL
Resident Leukocytes in Lung Ischemia-Reperfusion Injury$361,494
R01 · FY2008 · HL · contact PI
Resident Leukocytes in Lung Ischemia-Reperfusion Injury$361,494
R01 · FY2007 · HL · contact PI
Resident Leukocytes in Lung Ischemia-Reperfusion Injury$372,291
R01 · FY2006 · HL · contact PI
Resident Leukocytes in Lung Ischemia-Reperfusion Injury$373,441
R01 · FY2005 · HL
Nitric Oxide Regulation of Compensatory Lung Growth$296,000
R01 · FY2005 · HL
Nitric Oxide Regulation of Compensatory Lung Growth$296,000
R01 · FY2004 · HL
Nitric Oxide Regulation of Compensatory Lung Growth$296,000
R01 · FY2003 · HL
Nitric Oxide Regulation of Compensatory Lung Growth$285,200
R01 · FY2002 · HL